NSCLC patients - Globe Thesis

Keyword [NSCLC patients] Result: 1 - 20 \| Page: 1 of 7
1.	ERCC1 And Class Ⅲ β-tubulin Protein Expression In Relation To Tumor Response And Survival Of Stage Ⅲ/Ⅳ NSCLC Patients Treated With TP/NP Chemotherapy
2.	Meta Analysis Of P53 Expression On Response To Platinum-based Chemotherapy In NSCLC Patients And Experimental Study Of RAd-p53 Enhance Sensitivity Of NSCLC Cells To Cisplatin
3.	Increased IL-17-producing Cells Correlate With Poor Survival And Lymphangiogenesis In NSCLC Patients
4.	Study On The MAGE-A3 Polymorphism/Mutation And MRNA Expression Levels In NSCLC Patients
5.	The Analysis Of Relationship Between Immune Cells And TCM Syndrome Of Advanced NSCLC Patients
6.	The Control Study Of Lung Cancer No 1 Prescription On Immunology Function And Serum CYFRA21-1 In Late Refractory NSCLC Patients
7.	The Clinical Efficacy And Tolerability Of EGFR-TKI In Locally Advanced Or Metastatic NSCLC Patients
8.	The Clinical Observation Of The Application Of Jianpi Yishen Buqi Yangxue Method Treating Tumor Anemia Of Xuexu Type For Advanced-Stage Nsclc Patients
9.	Detecting Circulating Endothelial Cells In The Peripheral Blood Of Nsclc Patients And Its Application In The Treatment Of Nsclc Patients
10.	The Relationship Between MMP-7 MRNA Expression In Blood And Metastasis In NSCLC Patients
11.	Four Kinds Of Tumor Markers In Vitro Expression And The Clinical Significance Of Survivin Antibodies In NSCLC Patients
12.	The Clinical Significance Of Activated Circulating Endothelial Cells In The Peripheral Blood Of NSCLC Patients Treated With Chemotherapy
13.	The Pre-and Postoperative Change Of Th1/Th2 And Th17 On The Cellular Immune Function In Peripheral Blood Of NSCLC Patients
14.	The Evaluation And Clinical Significance Of Near Quality Of Life Of Late Stage Of Nsclc Patients Accepted Concurrent Chemoradiotherapy
15.	Study On The Expression Of HDGF And Its Role In Proliferation And Apoptosis In Stage I NSCLC Patients
16.	Observation On Effects Of Amifostine Plus PC Chemotherapy Scheme In Advanced NSCLC Patients Treated With Chemotherapy
17.	Effects Of Expression Of RRM1 And ERCC1 On Chemotherapy Response And Prognosis Of Advanced NSCLC Patients Treated By Cisplatin Combined With Gemcitabine Chemotherapy
18.	The Assay And Clinical Significance Of TC17 Cells And Its Main Effect Cytokine IL-17 In The Peripheral Blood Of NSCLC Patients
19.	The Correlation Analysis Of Currative Effect Between The Tumor Markers And The Treatment Of Gefitinib In Advanced NSCLC Patients
20.	The Significance Of Peri-operative Dynamic Changes Of Serum CYFRA21-1and M2-PK In NSCLC Patients
<<First <Prev Next> Last>> Jump to